Tatsunori Iwamura
Gifu Pharmaceutical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tatsunori Iwamura.
Tetrahedron | 1998
Tadashi Kataoka; Tetsuo Iwama; Shin-ichiro Tsujiyama; Tatsunori Iwamura; Shin-ichi Watanabe
Abstract The chalcogeno-Baylis-Hillman reaction catalyzed by sulfides and selenides, the group 16 element compounds, in the presence of Lewis acids was developed. The reactions proceeded smoothly by the use of 1 equiv of TiCl4 to give the coupling products in moderate to good yields. Bis-chalcogenides and related compounds were investigated as a catalyst, and 1,5-diselenocyclooctane gave the best result owing to stabilization of a cationic intermediate by the transannular interaction.
Tetrahedron | 2000
Tadashi Kataoka; Hironori Kinoshita; Tetsuo Iwama; Shin-ichiro Tsujiyama; Tatsunori Iwamura; Shin-ichi Watanabe; Osamu Muraoka; Genzoh Tanabe
Abstract Reactions of p -nitrobenzaldehyde ( 4 ) with methyl vinyl ketone ( 5 ) were conducted in the presence of TiCl 4 and dimethyl sulfide ( 3 ) or selenopyranone 6 . When the raw product was purified by column chromatography on silica gel, α-chloromethyl aldol 8 was obtained as a mixture of diastereoisomers 8a and 8b . In contrast, purification of the raw product by preparative TLC on silica gel gave α-methylene aldol 7 . The mechanism for the formation of α-chloromethyl aldol 8 and diasteroselection for the syn -isomer 8a and anti -isomer 8b are discussed.
Bioorganic & Medicinal Chemistry Letters | 2012
Kohji Matsumoto; Tominari Choshi; Mai Hourai; Yoshito Zamami; Kenji Sasaki; Takumi Abe; Minoru Ishikura; Noriyuki Hatae; Tatsunori Iwamura; Shigeo Tohyama; Junko Nobuhiro; Satoshi Hibino
We synthesized calothrixin B using our developed biomimetic method and derived N-alkyl-calothrixins A and B. The in vitro antimalarial activity of the calothrixin derivatives, including calothrixins A and B, against the Plasmodium falciparum FCR-3 strain was evaluated. All test compounds exhibited antimalarial activity over a concentration range of 6.4×10(-6)-1.2×10(-7) M.
Tetrahedron Letters | 1997
Tadashi Kataoka; Yoshihiro Banno; Shin-ichi Watanabe; Tatsunori Iwamura; Hiroshi Shimizu
Abstract Alkynylselenonium salts 2 and 5 were synthesized and treated with benzenesulfinic acid or its sodium salt in an alcohol. The reactions with sodium benzenesulfinate gave (Z)-β-alkoxyvinylsulfones 6 as main products, while the reactions with benzenesulfinic acid afforded the β-sulfonylvinylselenonium salts 11 and 12 in good yields.
Current Neuropharmacology | 2011
Yoko Hagino; Yukio Takamatsu; Hideko Yamamoto; Tatsunori Iwamura; Dennis L. Murphy; George R. Uhl; Ichiro Sora; Kazutaka Ikeda
3,4-Methylendioxymethamphetamine (MDMA) has both stimulatory and hallucinogenic properties which make its psychoactive effects unique and different from those of typical psychostimulant and hallucinogenic agents. The present study investigated the effects of MDMA on extracellular dopamine (DAex) and serotonin (5-HTex) levels in the striatum and prefrontal cortex (PFC) using in vivo microdialysis techniques in mice lacking DA transporters (DAT) and/or 5-HT transporters (SERT). subcutaneous injection of MDMA (3, 10 mg/kg) significantly increased striatal DAex in wild-type mice, SERT knockout mice, and DAT knockout mice, but not in DAT/SERT double-knockout mice. The MDMA-induced increase in striatal DAex in SERT knockout mice was significantly less than in wildtype mice. In the PFC, MDMA dose-dependently increased DAex levels in wildtype, DAT knockout, SERT knockout and DAT/SERT double-knockout mice to a similar extent. In contrast, MDMA markedly increased 5-HTex in wildtype and DAT knockout mice and slightly increased 5-HTex in SERT-KO and DAT/SERT double-knockout mice. The results confirm that MDMA acts at both DAT and SERT and increases DAex and 5-HTex.
European Journal of Pharmacology | 1995
Seishi Katsumata; Masabumi Minami; Takayuki Nakagawa; Tatsunori Iwamura; Masamichi Satoh
Abstract We investigated the binding characteristics of dihydroetorphine, 7,8-dihydro-7α-[1-(R)-hydroxyl-1-methylbutyl]-6,14-endoethano-tetrahydro-oripavine, and its effect on the inhibitory system of cyclic AMP production using cloned μ-, δ- and κ-opioid receptors expressed on Chinese hamster ovary cells. The Ki values of dihydroetrophine for the μ-, δ- and κ-opioid receptor were 4.5 × 10−10, 1.8 × 10−9 and 5.7 × 10−10 M, respectively. On the hand, those of morphine were 1.9 × 10−9, 1.4 × 10−6 and 1.3 × 10−7 M, respectively. Through all of these three types of opioid receptors, dihydroetorphine inhibited forskolin (10 μM)-stimulated cyclic AMP production via pertussis toxin-sensitive G protein(s), and the inhibitory effects were antagonized by co-application with opioid receptor antagonists. The IC50 values of dihydroetorphine for the inhibition of cyclic AMP production through the μ-, δ- and κ-opioid receptors were 4.2 × 10−11, 8.6 × 10−10 and 4.3 × 10−9 M, respectively. On the other hand, those of morphine were 2.6 × 10−8, 2.6 × 10−6 and 1.9 × 10−6 M, respectively. These results indicate that dihydroetorphine, unlike morphine which preferentially binds the μ-opioid receptor, binds not only μ- but also δ- and κ-opioid receptors with high affinity and acts as a more potent agonist than morphine for all of the three types of receptors.
Progress in Brain Research | 2007
Koichi Nisijima; Katsutoshi Shioda; Tatsunori Iwamura
This chapter is focused on drug-induced hyperthermia with special regard to use of antipsychotics and antidepressants for the treatment of schizophrenia and major depression, respectively. Neuroleptic malignant syndrome (NMS) develops during the use of neuroleptics, whereas serotonin syndrome is caused mainly by serotoninergic antidepressants. Although both syndromes show various symptoms, hyperthermia is the main clinical manifestation. In this review we describe the historical background, clinical manifestations, diagnosis, and differential diagnosis of these two syndromes based on our observations on the experimental and clinical data.
Tetrahedron Letters | 2002
Tadashi Kataoka; Hironori Kinoshita; Sayaka Kinoshita; Tatsunori Iwamura
The reactions of 1-(2-methylchalcogenophenyl)propynone with aldehydes gave 3-(hydroxyalkyl)chalcogenochromen-4-ones via the 6-endo-dig cyclization and aldol reaction. Selenochromen-4-ones were obtained in higher yields than the thiochromen-4-ones.
Tetrahedron | 2001
Tatsunori Iwamura; Masaru Fujita; Tetsuya Kawakita; Sayaka Kinoshita; Shin-ichi Watanabe; Tadashi Kataoka
Abstract The reactions of aldehydes with 3-buten-2-one ( 2 ) were conducted in the presence of BBr 3 ·Me 2 S or BCl 3 ·Me 2 S and then worked up with aqueous NaHCO 3 , affording the α-methylene aldol 3 , α-halomethyl aldol 4 or 6 , and α-halomethyl enones 5 or 7 , respectively. In contrast, the reactions quenched with water gave the α-halomethyl enones 5 or 7 in high yields, while the work-up with an aqueous 10% trimethylamine gave the α-methylene aldol 3 . The phenol 15 and half-acetal 16 were obtained from the reaction of p -nitrobenzaldehyde ( 1a ) with cyclohexenone ( 10 ).
Life Sciences | 1995
Masayuki Niwa; Luay Y. Al-Essa; Shuichiro Ohta; Ken-ichi Kohno; Masakatsu Nozaki; Kaito Tsurumi; Tatsunori Iwamura; Tadashi Kataoka
To find out the reason of weak addiction property of dihydroetorphine, we compared the affinities of dihydroetorphine to the type selective opioid receptor and inhibition effect on the adenylyl cyclase activity with those of etorphine. Dihydroetorphine and etorphine have almost the same binding affinities to all types (mu, delta, and kappa) of opioid receptors and antagonist binding sites, and have similar inhibition activities to forskolin stimulated adenylyl cyclase. However, dihydroetorphine showed significantly smaller value of DTNB-index compared with that of etorphine. This differentiation may explain partly the high analgesic with low dependence properties of dihydroetorphine.